Tag: Lymphoma

SARS-CoV-2 evolves antibody resistance in immunocompromised patient

Researchers in the United States who tracked the evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an immunocompromised patient found that convalescent plasma therapy was associated with the emergence of viral variants that were less susceptible to neutralizing antibodies. The SARS-CoV-2 virus is the agent responsible for the coronavirus 2019 (COVID-19) pandemic that

Lymph node Removal

Swollen or affected lymph nodes may sometimes need to be removed for examination. This is called lymph node biopsy. Lymph node biopsy A biopsy involves removal of whole or part of the lymph node to look under the microscope for signs of infection, or cancer. Lymph nodes are filters located at intervals between the lymph

Scientists identify a possible new treatment for diabetic retinopathy

About one in three diabetic patients develops diabetic retinopathy (DR), which can impair vision and lead to blindness. A new study in The American Journal of Pathology, published by Elsevier, provides clear evidence that high glucose increases the levels of enzymatic precursor — lysyl oxidase propeptide (LOX-PP) — that promotes cell death, which was verified

Combination therapies could help treat fatal lung cancers: Combining a new class of drug with two other compounds can significantly shrink lung tumors in mice and human cancer cells

Combining a new class of drug with two other compounds can significantly shrink lung tumours in mice and human cancer cells, finds a new study led by the Francis Crick Institute and The Institute of Cancer Research, London. The study, published in Science Translational Medicine, looked at G12C KRAS inhibitors. This new type of drug

Pancreas on a chip: Organ-on-a-chip and stem-cell tech combined: Organ-on-a-chip and stem-cell tech

By combining two powerful technologies, scientists are taking diabetes research to a whole new level. In a study led by Harvard University’s Kevin Kit Parker, microfluidics and human, insulin-producing beta cells have been integrated in an “Islet-on-a-Chip.” The new device makes it easier for scientists to screen insulin-producing cells before transplanting them into a patient,

Transfer of oncogene in colon cancer cells demonstrated

For years, doctors and scientists have known very little about why patients can receive drugs successfully for months, or even years, before developing a drug resistance. New University of Minnesota Medical School research proposes that there is a cellular as well as molecular cause to this phenomenon in colon cancer, with potential application to other

Helping transplanted stem cells stick around and do their jobs: New microgel encapsulation method paves the way for more efficient cell therapies

Bone marrow transplants of hematopoietic stem cells have become standard treatment for a host of conditions including cancers of the blood and lymphatic systems, sickle cell anemia, inherited metabolic disorders, and radiation damage. Unfortunately, many bone marrow transplants fail due to rejection by the patient’s immune system or graft-versus-host disease (in which the transplanted marrow

How inhaled fungal spores cause fatal meningitis

Pathogenic fungal spores capitalize on host immune cells to escape the lung and gain access to the brain to cause fatal disease in mice, according to a study published June 27 in the open-access journal PLOS Pathogens by Christina Hull of the University of Wisconsin-Madison, and colleagues. These insights into the interactions between pathogenic fungal

How hepatitis B and delta viruses establish infection of liver cells: Researchers explore infection using new cell culture system

Princeton University researchers have developed a new, scalable cell culture system that allows for detailed investigation of how host cells respond to infection with hepatitis B (HBV) and delta virus (HDV). The paper describing their findings was published online on June 18, 2019 in the journal Hepatology. HBV causes an acute illness that is usually

Special fibroblasts help pancreatic cancer cells evade immune detection

Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related deaths in the world. Mostly chemoresistant, PDAC so far has no effective treatment. Understanding the connective tissue, called stroma, that surrounds, nurtures, and even protects PDAC tumors, is key to developing effective therapeutics. “PDAC patients are diagnosed really late, so we don’t know they’re

New strategy of reprogramming regulatory T cells may improve cancer therapies: Converting immunosuppressive cells into inflammatory cells appears to prime tumors for immune checkpoint blockade

While therapies that harness the power of the immune system against cancer have made remarkable progress against certain types of tumors, they still remain ineffective in most cancer patients. A new study from the Center for Immunology and Inflammatory Diseases (CIID) at Massachusetts General Hospital (MGH) describes a method of reprogramming the regulatory T cells

Targeted therapy proves effective against aggressive rare blood cancer: Clinical study treating BPDCN with tagraxofusp led to first FDA approval for the disease

A multi-institutional clinical trial has given good results for a targeted therapy to treat a rare, aggressive blood cancer known as blastic plasmacytoid dendritic-cell neoplasm (BPDCN). Details on the trial, which supported Food and Drug Administration approval of the tagraxofusp therapy in December 2018, have been published in the New England Journal of Medicine. Diagnosed

New imaging technique reveals ‘burst’ of activity before cell death: Novel dual-PWS platform reveals connections between macromolecular structure and dynamic movement in the chromatin within eukaryotic cells

Studying the movement of tiny cells is no small task. For chromatin, the group of DNA, RNA, and protein macromolecules packed within our genome, motion is an integral part of its active role as a regulator of how our genes get expressed or repressed. “Understanding macromolecular motion is critical, but scientists know very little about

Specialized lung cells appear very early in development: Fetal signaling pathways may offer future targets for treating lung injury

Specialized lung cells appear in the developing fetus much earlier than scientists previously thought. A new animal study reports how cells that become alveoli, the tiny compartments in which gas exchange occurs in the lung, begin their specialized roles very early in prenatal life. The researchers say that investigating the fetal signaling pathways active in

Advancing therapy by measuring the ‘games’ cancer cells play

Cleveland: Despite rapid advances in targeted therapies for cancer, tumors commonly develop resistance to treatment. When resistance emerges, tumor cells continue to grow unchecked, despite all attempts to slow cancer progression. While mutations in cancer cells significantly affect drug sensitivity, it is increasingly recognized that ecological interactions between cells can also play a role. Jacob

Interaction between immune factors triggers cancer-promoting chronic inflammation: Blocking IL-33/Treg axis prevents development of skin and colon cancer in mice with chronic inflammation

A Massachusetts General Hospital (MGH) research team has identified interaction between two elements of the immune system as critical for the transformation of a protective immune response into chronic, cancer-promoting inflammation. In their report published in PNAS, the investigators demonstrate that elevated levels of the immune factor IL-33 and regulatory T cells (Tregs), which suppress